Thrombosis Research, 1879-2472

Tidskrift

Fler filtreringsmöjligheter
  1. The value of tomographic ventilation/perfusion scintigraphy (V/PSPECT) for follow-up and prediction of recurrence in pulmonary embolism.

    Alhadad, A., Miniati, M., Alhadad, H., Anders Gottsäter & Marika Bajc, 2012, I : Thrombosis Research.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Retrospective analysis of coagulation parameters at epidural anaesthesia catheter withdrawal after esophageal resection

    Anveden, P. A., Preutz, L., Rudin, Å., Flisberg, P., Eldh, E. & Ulf Schött, 2010, I : Thrombosis Research. 125, Suppl. 2, s. S177-S178

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  3. Uncarboxylated matrix Gla-protein (ucMGP) and osteocalcin (ucOC) increase postoperatively after major abdominal cancer and orthopedic surgery

    Anveden, P. A., Attila Frigyesi, Schurgers, L. & Ulf Schött, 2010, I : Thrombosis Research. 125, Suppl. 2, s. S178-S178 1 s.

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  4. Immune tolerance induction in patients with hemophilia A

    Jan Astermark, 2011, I : Thrombosis Research. 127, s. S6-S9

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Anti- and procoagulant activities in factor VII-deficient subjects

    Jan Astermark, Tengborn, L., Hedner, U. & Erik Berntorp, 2001, I : Thrombosis Research. 101, 6, s. 435-440

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Glycosaminoglycans in cancer treatment.

    Mattias Belting, 2014, I : Thrombosis Research. 133, s. S95-S101

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?

    Berndtsson, M., Eva Zetterberg, Holmström, M., Mahmoud Hourani Soutari, N., Mikovic, D., Elezovic, I. & Antovic, J. P., 2016 aug 1, I : Thrombosis Research. 144, s. 133-135 3 s.

    Forskningsoutput: TidskriftsbidragLetter

  8. Erik von Willebrand.

    Erik Berntorp, 2007, I : Thrombosis Research. 120, s. S3-S4

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. The von Willebrand Disease Prophylaxis Network (vWD PN): Exploring a treatment concept.

    Erik Berntorp & Abshire, T., 2006, I : Thrombosis Research. 18, s. S19-S22

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Von Willebrand: The scientist, the disease, the factor, and the treatment

    Erik Berntorp & Lillicrap, D., 2007, I : Thrombosis Research. 120, s. S1-S1

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  11. Haemate P/Humate-P: a systematic review.

    Erik Berntorp, 2009, I : Thrombosis Research. 124 Suppl 1, Nov, s. S11-S14

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex.

    Bhiladvala, P., Strandberg, K., Johan Stenflo & Johan Holm, 2006, I : Thrombosis Research. 118, Aug 10, s. 213-219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Warfarin persistence among stroke patients with atrial fibrillation.

    Björck, F., Renlund, H., Peter Svensson & Själander, A., 2015, I : Thrombosis Research. 136, 4, s. 744-748

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden.

    Björck, F., Sandén, P., Renlund, H., Peter Svensson & Själander, A., 2015, I : Thrombosis Research. 136, 2, s. 216-220

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. The APC-PCI concentration as an early marker of activation of blood coagulation A study of women on combined oral contraceptives

    Bremme, K., Hamad, R. R., Berg, E., Strandberg, K. & Johan Stenflo, 2012, I : Thrombosis Research. 130, 4, s. 636-639

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD

    Castaman, G., Tosetto, A., Cappelletti, A., Goodeve, A., Federici, A. B., Batlle, J., Meyer, D., Goudemand, J., Eikenboom, J. C. J., Schneppenheim, R., Budde, U., Ingerslev, J., Lethagen, S., Hill, F., Peake, I. R. & Rodeghiero, F., 2010, I : Thrombosis Research. 126, 3, s. 227-231

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event.

    Chaireti, R., Rajani, R., Bergquist, A., Melin, T., Friis-Liby, I-L., Kapraali, M., Kechagias, S., Lindahl, T. L. & Almer, S., 2014, I : Thrombosis Research. 134, 2, s. 455-461

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Treatment with recombinant human erythropoietin induces a moderate rise in hematocrit and thrombin antithrombin in healthy subjects

    Naomi Clyne, Berglund, B. & Egberg, N., 1995 jul 1, I : Thrombosis Research. 79, 1, s. 125-129 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Effects of hemodialysis and longterm erythropoietin treatment on protein C, and on free and total protein S

    Naomi Clyne, Egberg, N. & Lins, L. E., 1995 okt 15, I : Thrombosis Research. 80, 2, s. 161-168 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Targeting exosites of activated protein C as therapeutic possibility?

    Björn Dahlbäck, 2014, I : Thrombosis Research. 133, 6, s. 963-964

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  21. Clinical probability assessment and D-dimer determination in patients with suspected deep vein thrombosis, a prospective multicenter management study.

    Elf, J. L., Strandberg, K., Nilsson, C. & Svensson, P. J., 2009, I : Thrombosis Research. May 29, s. 612-616

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. A comprehensive study of ovine haemostasis to assess suitability to model human coagulation

    Foley, S. R., Solano, C., Simonova, G., Spanevello, M. M., Bird, R. J., John W Semple, Jackson, D. E., Schibler, A., Fraser, J. F. & Fung, Y. L., 2014 aug, I : Thrombosis Research. 134, 2, s. 468-73 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs)

    Grasso, S., Ariane Neumann, Lang, I. M., Etscheid, M., von Köckritz-Blickwede, M. & Kanse, S. M., 2018, I : Thrombosis Research. 161, s. 36-42 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses

    Grzymala-Lubanski, B., Sjalander, S., Renlund, H., Peter Svensson & Sjalander, A., 2013, I : Thrombosis Research. 131, 2, s. 130-134

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Mechanical heart valve prosthesis and warfarin - Treatment quality and prognosis.

    Grzymala-Lubanski, B., Ashkan Labaf, Englund, E., Peter Svensson & Själander, A., 2014, I : Thrombosis Research. 133, 5, s. 795-798

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Increased thrombin generation in women with a history of preeclampsia

    Hamad, R. R., Curvers, J., Erik Berntorp, Eriksson, M. J. & Bremme, K., 2009, I : Thrombosis Research. 123, 4, s. 580-586

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Association between variation in ADAMTS13 and aneurysmal subarachnoid hemorrhage

    Hanson, E., Olsson, S., Bayazit, B., Csajbok, L. Z., Nylen, K., Nellgård, B. & Jern, C., 2013, I : Thrombosis Research. 131, 1, s. 99-101

    Forskningsoutput: TidskriftsbidragLetter

  28. History of rFVIIa therapy.

    Hedner, U., 2010, I : Thrombosis Research. 125 Suppl 1, s. S4-S6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke.

    Andreas Hillarp, Palmqvist, B., Lethagen, S., Villoutreix, B. O. & Mattiasson, I., 2003, I : Thrombosis Research. 112, 5-6, s. 275-283

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients

    Hjellström, L. & Ashkan Labaf, 2018, I : Thrombosis Research. 163, s. 180-184

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin

    Johan Holm, Andreas Hillarp, Erhardt, L. RW. & Erik Berntorp, 1999, I : Thrombosis Research. 96, 3, s. 205-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg

    Lars Holmberg, R Ljung & Nilsson, I. M., 1983 jul 1, I : Thrombosis Research. 31, 1, s. 41-50 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Effect on primary haemostasis of prophylactic regimens of low molecular weight heparin, unfractionated heparin, dextran and their combinations. An animal experimental study

    Jan Holst, Lindblad, B., Mätzsch, T. & Bergqvist, D., 1992, I : Thrombosis Research. 65, 4-5, s. 651-656

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man

    Jan Holst, Lindblad, B., Bergqvist, D., Hedner, U., Nordfang, O. & Ostergaard, P., 1997, I : Thrombosis Research. 86, 4, s. 343-348

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor

    Jan Holst, Lindblad, B., Westerlund, G., Bregengaard, C., Ezban, M., ØStergaard, P. B., Nordfang, O. & Hedner, U., 1996 feb 15, I : Thrombosis Research. 81, 4, s. 461-470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis

    Jan Holst, Lindblad, B., Wedeberg, E., Bergqvist, D., Nordfang, O., Østergaard, P. B. & Hedner, U., 1993 dec 1, I : Thrombosis Research. 72, 5, s. 467-470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Current view and outcome of ITI therapy: A change over time?

    Holstein, K., Batorova, A., Carvalho, M., Fijnvandraat, K., Holme, P., Kavakli, K., Lambert, T., Rocino, A., Jiménez-Yuste, V. & J. Astermark, 2016 dec, I : Thrombosis Research. 148, s. 38-44

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study.

    Jakubowski, J. A., Angiolillo, D. J., Zhou, C., Small, D. S., Moser, B. A., Ten Berg, J. M., Brown, P. B., James, S., Winters, K. J. & David Erlinge, 2014, I : Thrombosis Research. 134, 3, s. 552-557

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation

    Jansson, M., Själander, S., Sjögren, V., Renlund, H., B. Norrving & Själander, A., 2020, I : Thrombosis Research. 185, s. 135-141 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters

    Anna Jerkeman, Jan Astermark, Hedner, U., Lethagen, S., Olsson, C-G. & Erik Berntorp, 2000, I : Thrombosis Research. 98, 6, s. 467-471

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.

    Jonsson, M., Andreas Hillarp & Peter Svensson, 2004, I : Thrombosis Research. 114, 2, s. 83-89

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers

    Kalani, M., Silveira, A., Blomback, M., Jan Apelqvist, Eliasson, B., Eriksson, J. W., Fagrell, B., Torffvit, O., Hamsten, A. & Jorneskog, G., 2007, I : Thrombosis Research. 120, 5, s. 653-661

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A: Interim analysis from the LEOPOLD Kids extension study

    Kenet, G., Rolf Ljung, Rusen, L., Kerlin, B. A., Blanchette, V., Saulytė Trakymienė, S., Uscatescu, V., Beckmann, H., Tseneklidou-Stoeter, D. & Church, N., 2020 maj, I : Thrombosis Research. 189, s. 96-101 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 3 Nästa